Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report

Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report

<p>Abstract</p> <p>Background</p> <p>Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme for producing γ-aminobutyric acid, and it has been suggested that antibodies against GAD play a role in neurological conditions and type 1 diabetes. However, it is not kno...

Full description

Bibliographic Details
Main Authors: Takagi Masahito, Yamasaki Hiroshi, Endo Keiko, Yamada Tetsuya, Kaneko Keizo, Oka Yoshitomo, Mori Etsuro
Format: Article
Language:English
Published: BMC 2011-12-01
Series:BMC Neurology
Subjects:
anti-glutamic acid decarboxylase antibodies
stiff person syndrome
cognitive decline
frontal dysfunction
working memory
Online Access:http://www.biomedcentral.com/1471-2377/11/156

Internet

http://www.biomedcentral.com/1471-2377/11/156

Similar Items